Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

MREO

Mereo BioPharma Group plc

CIK 0001719714 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.29
↓ 0.00 (-0.99%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals, Technicals

Key stats

Market Cap
$46.37M
P/E Ratio
-1.65
EPS
-0.05
Dividend Yield
Not covered
52W Position
4%
Beta
1.50

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.62
P/S
1,495.94
EV/Revenue
524.40
ROE
-98.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 4%
$0.20$2.37

Latest Financials

2025-12-31 FY
Revenue
$500.00K
Net Income
-$41.88M
Total Assets
$45.92M
Free Cash Flow
-$30.99M

Recent news